# OnCo record paper-a3961-intermediate-risk-neuroblastoma-baker-nejm-2010 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-a3961-intermediate-risk-neuroblastoma-baker-nejm-2010/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-a3961-intermediate-risk-neuroblastoma-baker-nejm-2010" ;
  schema:name "A3961: outcome after reduced chemotherapy for intermediate-risk neuroblastoma"@en ;
  schema:description "Cutting chemotherapy to four or eight cycles based on tumour biology kept three-year survival above 96 percent in intermediate-risk neuroblastoma, showing these children could be safely treated with substantially less."@en ;
  schema:url <https://onco.cc/key-papers/paper-a3961-intermediate-risk-neuroblastoma-baker-nejm-2010/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1001527>, <https://pubmed.ncbi.nlm.nih.gov/20879880/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1001527> ;
  schema:datePublished "2010"^^xsd:gYear ;
  schema:author "Baker DL, Schmidt ML, Cohn SL, et al." ;
  onco:cancers <https://onco.cc/cancers/neuroblastoma-intermediate-risk/> ;
  onco:journals <https://onco.cc/journals/nejm/> .